Tirzepatide, also known by its brand name Mounjaro and Zepbound, is another medicine like Wegovy and Ozempic that helps people with Type 2 diabetes lose weight.

Tirzepatide, however, is a bit different and special. While Wegovy and Ozempic use one helper (GLP-1) to control hunger and help the body use food properly, Tirzepatide uses two helpers (GLP-1 and GIP) to do an even better job.

So, how does this work? GLP-1 helps by making your digestion slower, so you feel full with less food, and it tells your brain that you're not that hungry. This means you won't feel like eating too much, especially snacks that aren't good for you. On the other hand, GIP also helps control the sugar in your blood and slows down how fast your stomach digests food.

Ultimately it will depend on your physiology, your response to treatment and diet. Most patients on Tirzepatide had an average loss of 15% to 22% after 72 weeks of treatment.

Like all medicines, Tirzepatide can cause some side effects, especially when you first start taking it. This medicine changes how your body deals with food, so it might make your stomach feel upset at first. Some common side effects that people might feel include:

• Diarrhea

• Feeling like you might throw up (nausea)

• Actually throwing up (vomiting)

• Stomach aches

• Having a hard time going to the bathroom (constipation)

• Not feeling hungry

• Burning feeling in the chest (heartburn)

• Red or irritated skin where the medicine was injected

There can also be more serious side effects like allergic reactions, a higher chance of getting thyroid cancer, problems with the gallbladder, and low blood sugar (which is when you might feel shaky, dizzy, or very hungry).